Managing adherence, exposure, and toxicity in oral anticancer therapies

被引：0
|
作者：
Kazuo Kobayashi [1 ]
机构：
[1] The Cancer Institute Hospital of JFCR,Department of Pharmacy
来源：
Journal of Pharmaceutical Health Care and Sciences | / 11卷 / 1期
关键词：
Oral anticancer agents; Adherence; Occupational exposure; Hand-foot skin reaction; Hypothyroidism; Pharmacist intervention; Medication safety; Oncology pharmacy; Patient education; Adverse effect management;
D O I：
10.1186/s40780-025-00437-2
中图分类号：
学科分类号：
摘要：
The management of adherence, exposure risk, and adverse effects in oral anticancer agents (OAAs) is essential for optimizing patient outcomes in oncology pharmacy. This review highlights key efforts to enhance adherence, reduce occupational exposure, and improve adverse effect management in OAA therapy.
引用
收藏
相关论文
共 50 条
  • [31] Adherence and patients' attitude toward oral anticancer drugs: A prospective series of 226 patients focusing onto targeted therapies
    Barthelemy, Philippe
    Dourthe, Louis-Marie
    Serra, Sebastian
    Asmane-De la Porte, Irene
    Prim, Nathalie
    Ame, Shanti
    Litique, Valere
    Giron, Cathy
    Goldbarg, Veronica
    Fornecker, Luc
    Duclos, Brigitte
    Kurtz, Jean Emmanuel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Adherence and patients' attitude towards oral anticancer drugs: a prospective series of 226 patients focusing onto targeted therapies
    Barthelemy, P.
    Dourthe, L. M.
    Serra, S.
    De la Porte, I.
    Prim, N.
    Ame, S.
    Litique, V.
    Quoix, E.
    Goldbarg, V.
    Kurtz, J. E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S415 - S415
  • [33] Adherence to Oral Anticancer Therapeutics in the Gynecologic Oncology Population
    Watson, Catherine H.
    Fish, Laura J.
    Falkovic, Margaret
    Monuszko, Karen
    Lorenzo, Amelia
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    Davidson, Brittany A.
    OBSTETRICS AND GYNECOLOGY, 2020, 136 (06): : 1145 - 1153
  • [34] Adherence and patients' experiences with the use of oral anticancer agents
    Timmers, Lonneke
    Boons, Christel C. L. M.
    Kropff, Femke
    van de Ven, Peter M.
    Swart, Eleonora L.
    Smit, Egbert F.
    Zweegman, Sonja
    Kroep, Judith R.
    Timmer-Bonte, Johanna N. H.
    Boven, Epie
    Hugtenburg, Jacqueline G.
    ACTA ONCOLOGICA, 2014, 53 (02) : 259 - 267
  • [35] Medication adherence to oral anticancer drugs: systematic review
    Huang, Wen-Chuan
    Chen, Chung-Yu
    Lin, Shun-Jin
    Chang, Chao-Sung
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (04) : 423 - 432
  • [36] Factors Influencing Medication Adherence to Oral Anticancer Drugs
    Lee, Yeon Hee
    Jeong, Ihn Sook
    ASIAN ONCOLOGY NURSING, 2013, 13 (04) : 201 - 209
  • [37] Call to Action for Improving Oral Anticancer Agent Adherence
    Levit, Laura A.
    Arora, Shaily
    Kluetz, Paul G.
    Magnuson, Allison
    Rahman, Atiqur
    Harvey, R. Donald
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (10) : 1036 - +
  • [38] Adherence to oral hormonal anticancer agents in breast cancer
    Gori, Stefania
    Modena, Alessandra
    Foglietta, Jennifer
    Verze, Matteo
    Inno, Alessandro
    Casarin, Alessandra
    Russo, Antonio
    Nicolis, Fabrizio
    TUMORI JOURNAL, 2023, 109 (03): : 262 - 268
  • [39] A review on adherence management in patients on oral cancer therapies
    Wood, Leslie
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2012, 16 (04) : 432 - 438
  • [40] The broadening scope of oral mucositis and oral ulcerative mucosal toxicities of anticancer therapies
    Elad, Sharon
    Yarom, Noam
    Zadik, Yehuda
    Kuten-Shorrer, Michal
    Sonis, Stephen T.
    CA-A CANCER JOURNAL FOR CLINICIANS, 2022, 72 (01) : 57 - 77
12345